The LCS complete knee offers grit-blast textured components for cemented implantation and POROCOAT Porous Coated patellar, femoral and tibial components for cementless fixation.
...ak system includes a cruciate sparing version whic...th both resurfacing and inset patellas. Precision ...atics and fit with tibial articular surface and pa...ocations provide easy intraoperative change of siz...
The Balanced Knee System provides instrumentation designed to achieve proper tissue balancing and alignment with user-friendly instrumentation that provides reproducible results.
Advance Posterior Stabilized Total Knee systems improves patellofemoral kinematics, reduces wear rate potential, increases resistance to posterior tibial dislocation, achieves at least 120o flexion i
Medicine Products:(Date:8/29/2008)...SNewswire/ -- The following is a,statement by Matt... Kids:, For the second time in a month, Philip Mo... and promotion of a concert in a developing countr...ngaging in cigarette,marketing that appeals to chi...s been forced to withdraw from,an August 30 reunio...
(Date:8/29/2008)... change that raises odds for malignancy, study fin...-- Some Japanese survivors of the World War II ato...ced key genetic changes that may have sparked the ...dicates. , Papillary thyroid cancer (PTC) is ty...volving the so-called BRAF gene. But Japanese rese...
(Date:8/29/2008)...wire-FirstCall/ -- InterMune, Inc.,(Nasdaq: ITMN ...CEO and,President of InterMune, will present at th...Boston on September 4, 2008 at 10:55 a.m. EDT., T... investors and other,interested parties may log on...porate website at http://www.intermune.com . The ...
(Date:8/29/2008)...re-FirstCall/ -- Landauer, Inc. (NYSE:,LDR) announ...egular,quarterly cash dividend of $0.50 per share ...d will be paid on October 3, 2008, to shareholders..., Landauer is the leading provider of analytical ...al radiation exposure. For more than 50 years,the...
Breaking Medicine News(10 mins):Health News:Philip Morris International Forced to Drop Another Concert Sponsorship; Philippines Health Department Applauded for Taking Action 2Health News:Some Hiroshima Survivors at Thyroid Cancer Risk 2Health News:Some Hiroshima Survivors at Thyroid Cancer Risk 3...roved for treatment to breast cancer patients with...ith breast cancer// produce this Her-2 protein in ...ggressive and resist chemotherapy and Tamoxifen th...in is a humanized monoclonal antibody prepared for...
...ired by teenagers in Scotland who wish to get tatt... studios will also be subject to mandatory licensi...e hygiene. This is applicable to all those who are... behind the exercise is to reduce the possibilitie...
...anies which are proved to be better than older dru...tual benefit of these drugs could be realized repo...rder). MSF (Medicine sans Frontiers) have accused...elling their new drugs in Africa. MSF is providing...
...measles outbreaks in the quake-hit Pakistan as the...ting temperatures//. Pakistan-administered Kashmir...gainst the disease, with nearly 200,000 under-five...ll. An extra dose of oral polio vaccine was also a...
Other Medicine News:(Date:8/26/2008).../- XTENT, Inc.,(Nasdaq: XT...llow-up data,from the CUSTOM II trial was publishe...urnal, EuroIntervention. The lead author of the ar...y Medical Center Utrecht, Utrecht,The Netherlands...clinical,sites across Europe., The one-year CUSTO...
(Date:8/25/2008)...d in Menstrual Blood May Offer Long-Lasting ..., OLDSMAR, Fla., Aug. 25 /- Time. It...ee that there never seems to be enough,of it. And ...omething just,for herself usually pales in compari...y has led many women in need of quality time to se...
(Date:8/25/2008)...calls it a ,miracle, LATHAM, N.Y., Aug. 25 /PRNe...ded Radiation Therapy program at Community Care Ph...patients using RapidArc(TM),radiotherapy technolog...vancement that delivers a highly-precise image-gui...ment in two minutes or less., RapidArc treatments...
(Date:8/22/2008)...l Sponsored by Medical Research Council, LEXINGTO...s,Pharmaceuticals, Inc. (Nasdaq: IDEV ) announced...P 301, a Phase III clinical trial of PRO 2000, the...revention of HIV and other,sexually transmitted in...gdom,s Medical Research Council (MRC) and conducte...
Breaking Medicine Technology:XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 2XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 3XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 4Going Beyond 'Spa Day': Giving Women the Opportunity to Do Something Proactive Which May Lead to Long Term Health Benefits 2Image Guided Radiation Therapy in Latham, NY. Now Fighting Cancer Using Fast and Precise RapidArc(TM) Radiotherapy Technology 2Image Guided Radiation Therapy in Latham, NY. Now Fighting Cancer Using Fast and Precise RapidArc(TM) Radiotherapy Technology 3Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 2Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 3Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 4Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 5Trust for Americas Health 3A New E Coli Outbreak Confusion Around Salmonella Show Food Safety System Remains Broken 23204 1Trust for Americas Health 3A New E Coli Outbreak Confusion Around Salmonella Show Food Safety System Remains Broken 23204 2Boston Scientific Announces FDA Approval for PROMUS 28TM 29 Everolimus Eluting Coronary Stent System 6366 1Boston Scientific Announces FDA Approval for PROMUS 28TM 29 Everolimus Eluting Coronary Stent System 6366 2Boston Scientific Announces FDA Approval for PROMUS 28TM 29 Everolimus Eluting Coronary Stent System 6366 3Boston Scientific Announces FDA Approval for PROMUS 28TM 29 Everolimus Eluting Coronary Stent System 6366 4Search for salt tolerant grasses aims to improve roadside plantings 3881 1Search for salt tolerant grasses aims to improve roadside plantings 3881 2New Drug Slows Thyroid Cancer 23202 1New Drug Slows Thyroid Cancer 23202 2...DNA Therapeutics,S.A. an emerging pharmaceutical c...nounces today the elucidation of a new mechanism,o...its,first-in-class antitumoral lead molecule Dbait...Association for Cancer,Research annual meeting 200...ntation itself will be available from April 16th o...
...07 - Affymax, Inc.,(Nasdaq:AFFY) today announced t...ial of Hematide(TM) dosed monthly in dialysis pati...ey Foundation (NKF),2007 Spring Clinical Meeting. ...patients previously treated with,three-times weekl...obin (Hgb) levels can be maintained at clinically ...
Other Medicine Technology:DNA Therapeutics Reports a Novel Mechanism of Action and a,Biomarker of its Lead Molecule Dbait That Open an Innovative,Pathway-Targeting in Molecular Cancer Therapy 2DNA Therapeutics Reports a Novel Mechanism of Action and a,Biomarker of its Lead Molecule Dbait That Open an Innovative,Pathway-Targeting in Molecular Cancer Therapy 3Affymax Announces Results From Phase 2 Clinical Trial of Hematide,for the Treatment of Anemia in Dialysis Patients 2Affymax Announces Results From Phase 2 Clinical Trial of Hematide,for the Treatment of Anemia in Dialysis Patients 3